245 related articles for article (PubMed ID: 33563114)
1. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis.
Li J; Wang Y; Li J; Che G
Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114
[TBL] [Abstract][Full Text] [Related]
2. High pretreatment D-dimer level is an independent unfavorable prognostic factor of small cell lung cancer: A systematic review and meta-analysis.
Deng HY; Ma XS; Zhou J; Wang RL; Jiang R; Qiu XM
Medicine (Baltimore); 2021 Apr; 100(15):e25447. PubMed ID: 33847650
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Zhu LR; Li J; Chen P; Jiang Q; Tang XP
Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
Wang Y; Wu Y; Li J; Li J; Che G
Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
[TBL] [Abstract][Full Text] [Related]
6. High pretreatment plasma D-dimer levels are associated with shorter overall survival in patients with small cell lung cancer.
Fan S; Zhao G; An G
J Int Med Res; 2019 Jan; 47(1):215-224. PubMed ID: 30270808
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
Jin J; Yang L; Liu D; Li WM
Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis.
Huang L; Shi Y
Thorac Cancer; 2020 Nov; 11(11):3252-3259. PubMed ID: 32959954
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma D-dimer levels in patients with small-cell lung cancer.
Chen Y; Yu H; Wu C; Li J; Jiao S; Hu Y; Tao H; Wu B; Li A
Biomed Pharmacother; 2016 Jul; 81():210-217. PubMed ID: 27261596
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
Lu Y; Jiang J; Ren C
PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis.
Xie Y; Li H; Hu Y
Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis.
Tian Z; Liang C; Zhang Z; Wen H; Feng H; Ma Q; Liu D; Qiang G
World J Surg Oncol; 2020 May; 18(1):116. PubMed ID: 32473655
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis.
Li W; Tang Y; Song Y; Chen SH; Sisliyan N; Ni M; Zhang H; Zeng Q; Hou B; Xie X; Chang D
Cell Physiol Biochem; 2018; 45(4):1663-1676. PubMed ID: 29490291
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer.
Zhang Y; Cao J; Deng Y; Huang Y; Li R; Lin G; Dong M; Huang Z
Clinics (Sao Paulo); 2020; 75():e993. PubMed ID: 32130355
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis.
Wang Z; Wang Y; Zhang X; Zhang T
Clin Chim Acta; 2018 Nov; 486():303-310. PubMed ID: 30138620
[TBL] [Abstract][Full Text] [Related]
18. The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis.
Ma M; Cao R; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
J Cardiothorac Surg; 2021 Aug; 16(1):243. PubMed ID: 34454552
[TBL] [Abstract][Full Text] [Related]
19. Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer.
Deng T; Zhang J; Meng Y; Zhou Y; Li W
Medicine (Baltimore); 2018 Sep; 97(38):e12524. PubMed ID: 30235773
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis.
Yuan Y; Zhong H; Ye L; Li Q; Fang S; Gu W; Qian Y
BMC Pulm Med; 2020 Apr; 20(1):96. PubMed ID: 32312252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]